{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:28:24Z","timestamp":1791235704300,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019944","name":"Sanofi Aventis GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019944","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.pcd.2026.04.012","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:17:41Z","timestamp":1777612661000},"page":"411-417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness and safety of connected solutions among people with type 2 diabetes uncontrolled on oral anti-diabetic drugs: A randomized real-world study on Insultrate"],"prefix":"10.1016","volume":"20","author":[{"given":"Chieh-Hua","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Hsun","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horng-Yih","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Hsien","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Ze","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Ying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Te","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2456-0574","authenticated-orcid":false,"given":"Yi-Sun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Ting","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcd.2026.04.012_bib1","unstructured":"Facts & figures. Available at: \u3008https:\/\/idf.org\/about-diabetes\/diabetes-facts-figures\/\u3009 Accessed 15 April, 2025."},{"key":"10.1016\/j.pcd.2026.04.012_bib2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s13300-015-0137-8","article-title":"National variations in comorbidities, glycosylated hemoglobin reduction, and insulin dosage in asian patients with type 2 diabetes: the FINE-Asia registry","volume":"6","author":"Ji","year":"2015","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.pcd.2026.04.012_bib3","article-title":"Distinct associations of self-monitoring of blood glucose with glycemic control and hypoglycemia between groups of recently diagnosed and long-term follow-up type 2 diabetes: the Taiwan Diabetes Registry","volume":"75","author":"Wang","year":"2021","journal-title":"Int J. Clin. Pr."},{"key":"10.1016\/j.pcd.2026.04.012_bib4","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s13300-024-01570-1","article-title":"Real-world effectiveness of the Gla-300 + Cap + app program in adult users living with type 2 diabetes in Taiwan","volume":"15","author":"Wang","year":"2024","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.pcd.2026.04.012_bib5","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.2337\/dc25-S009","article-title":"Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2025","volume":"48","author":"American Diabetes Association Professional Practice C. 9","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2026.04.012_bib6","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2026.04.012_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13690-024-01450-x","article-title":"Prognostic effectiveness of interactive vs. non-interactive mobile app interventions in type 2 diabetes: a systematic review and meta-analysis","volume":"82","author":"Tang","year":"2024","journal-title":"Arch. Public Health"},{"key":"10.1016\/j.pcd.2026.04.012_bib8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/dci19-0062","article-title":"Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group","volume":"43","author":"Fleming","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2026.04.012_bib9","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.2337\/dc16-0346","article-title":"Do Mobile Phone Applications Improve Glycemic Control (HbA1c) in the Self-management of Diabetes? A Systematic Review, Meta-analysis, and GRADE of 14 Randomized Trials","volume":"39","author":"Hou","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2026.04.012_bib10","article-title":"Device-supported automated basal insulin titration in adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"35","author":"Luo","year":"2023","journal-title":"Lancet Reg. Health West Pac."},{"key":"10.1016\/j.pcd.2026.04.012_bib11","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s13300-022-01245-9","article-title":"Impact of my dose coach app frequency of use on clinical outcomes in type 2 diabetes","volume":"13","author":"Unnikrishnan","year":"2022","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.pcd.2026.04.012_bib12","doi-asserted-by":"crossref","DOI":"10.2196\/23227","article-title":"The effects of continuous usage of a diabetes management app on glycemic control in real-world clinical practice: retrospective analysis","volume":"23","author":"Tu","year":"2021","journal-title":"J. Med Internet Res."},{"key":"10.1016\/j.pcd.2026.04.012_bib13","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1177\/1932296820942286","article-title":"A digital lifestyle program in outpatient treatment of type 2 diabetes: a randomized controlled study","volume":"15","author":"Hilmarsdottir","year":"2021","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.pcd.2026.04.012_bib14","doi-asserted-by":"crossref","DOI":"10.2337\/db19-138-LB","article-title":"138-LB: Digital-tool-supported basal insulin (BI) titration: real-world effectiveness of my dose coach in India","volume":"68","author":"MODI","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.pcd.2026.04.012_bib15","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/19322968221148756","article-title":"Evaluation of a digital health tool for titration of basal insulin in people with type 2 diabetes: rationale and design of a randomized controlled trial","volume":"18","author":"Hermanns","year":"2024","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.pcd.2026.04.012_bib16","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1177\/19322968211034533","article-title":"Effect of digital-tool-supported basal insulin titration algorithm in reaching glycemic control in patients with type 2 diabetes in Mexico","volume":"16","author":"Tamez-Perez","year":"2022","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.pcd.2026.04.012_bib17","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0140-6736(19)30368-X","article-title":"Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial","volume":"393","author":"Bergenstal","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.pcd.2026.04.012_bib18","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1177\/1932296818821706","article-title":"A randomized controlled, treat-to-target study evaluating the efficacy and safety of insulin glargine 300 U\/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes","volume":"13","author":"Davies","year":"2019","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.pcd.2026.04.012_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4158\/EP14079.OR","article-title":"Patient-led versus physician-led titration of insulin glargine in patients with uncontrolled type 2 diabetes: a randomized multinational ATLAS study","volume":"21","author":"Garg","year":"2015","journal-title":"Endocr. Pr."},{"key":"10.1016\/j.pcd.2026.04.012_bib20","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12325-013-0036-1","article-title":"Insulin degludec once-daily in type 2 diabetes: simple or step-wise titration (BEGIN: once simple use)","volume":"30","author":"Philis-Tsimikas","year":"2013","journal-title":"Adv. Ther."},{"key":"10.1016\/j.pcd.2026.04.012_bib21","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.2337\/dc16-0419","article-title":"A Smartphone Application to Deliver a Treat-to-Target Insulin Titration Algorithm in Insulin-Naive Patients With Type 2 Diabetes: A Pilot Randomized Controlled Trial","volume":"39","author":"Bee","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2026.04.012_bib22","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2147\/DMSO.S244826","article-title":"Achieving Effective and Efficient Basal Insulin Optimal Management by Using Mobile Health Application (APP) for Type 2 Diabetes Patients in China","volume":"13","author":"Cai","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.pcd.2026.04.012_bib23","article-title":"Use of smartphone application versus written titration charts for basal insulin titration in adults with type 2 diabetes and suboptimal glycaemic control (My Dose Coach): multicentre, open-label, parallel, randomised controlled trial","volume":"33","author":"Hermanns","year":"2023","journal-title":"Lancet Reg. Health Eur."},{"key":"10.1016\/j.pcd.2026.04.012_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/cen.14956","article-title":"Efficacy of a basal insulin dose management smartphone application for controlling fasting blood glucose in patients with type-2 diabetes mellitus: A single-centre, randomised clinical study","volume":"99","author":"Luo","year":"2023","journal-title":"Clin. Endocrinol. (Oxf. )"},{"key":"10.1016\/j.pcd.2026.04.012_bib25","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1177\/19322968221090521","article-title":"A Smartphone-Based Application to Assist Insulin Titration in Patients Undergoing Basal Insulin-Supported Oral Antidiabetic Treatment","volume":"17","author":"Tews","year":"2023","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.pcd.2026.04.012_bib26","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.eprac.2022.04.006","article-title":"New digital health technologies for insulin initiation and optimization for people with type 2 diabetes","volume":"28","author":"Kerr","year":"2022","journal-title":"Endocr. Pr."},{"key":"10.1016\/j.pcd.2026.04.012_bib27","doi-asserted-by":"crossref","DOI":"10.2337\/db23-985-P","article-title":"985-P: Is Insulin Titration Supported by a Titration App Safe? Safety Results of an RCT","volume":"72","author":"Kulzer","year":"2023","journal-title":"Diabetes"},{"key":"10.1016\/j.pcd.2026.04.012_bib28","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s13300-023-01404-6","article-title":"A randomised control trial to explore the impact and efficacy of the healum collaborative care planning software and app on condition management in the type 2 diabetes mellitus population in NHS primary care","volume":"14","author":"Heald","year":"2023","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.pcd.2026.04.012_bib29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s13300-020-00995-8","article-title":"Comparison of patient-led and physician-led insulin titration in japanese type 2 diabetes mellitus patients based on treatment distress, satisfaction, and self-efficacy: the COMMIT-patient study","volume":"12","author":"Ishii","year":"2021","journal-title":"Diabetes Ther."}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991826000847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991826000847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:11:31Z","timestamp":1784232691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751991826000847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1751991826000847"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2026.04.012","relation":{},"ISSN":["1751-9918"],"issn-type":[{"value":"1751-9918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of connected solutions among people with type 2 diabetes uncontrolled on oral anti-diabetic drugs: A randomized real-world study on Insultrate","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2026.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of Primary Care Diabetes Europe.","name":"copyright","label":"Copyright"}]}}